FDA decision: Ivonescimab by Summit Therapeutics (in 2026)
Financials Prediction Markets
Loading
Loading
Loading
Loading
Loading
Loading
Loading
Loading
Loading
Loading
Loading
Loading
Loading
Loading
Loading
Loading
Loading
Loading
Loading
Loading
Loading
Loading
Loading